406 results
8-K
EX-99.1
SNGX
Soligenix Inc
31 May 24
Soligenix Announces Reverse Stock Split
8:00am
Institute of Allergy and Infectious Diseases (NIAID), the Defense Threat Reduction Agency (DTRA) and the Biomedical Advanced Research and Development … will not be reduced or discontinued due to difficulties or delays in clinical trials or due to lack of progress or positive results from research and development
8-K
EX-99.1
SNGX
Soligenix Inc
24 May 24
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
4:05pm
Institute of Allergy and Infectious Diseases (NIAID), the Defense Threat Reduction Agency (DTRA) and the Biomedical Advanced Research and Development … will not be reduced or discontinued due to difficulties or delays in clinical trials or due to lack of progress or positive results from research and development
424B3
SNGX
Soligenix Inc
10 May 24
Prospectus supplement
4:16pm
,
December 31,
Assets
(unaudited)
Current assets:
Cash and cash equivalents
Contracts and grants receivable
Unbilled revenue
Research and development … furniture and equipment, net
Right-of-use lease assets
Research and development incentives receivable, net of current portion
Total assets
8-K
EX-99.1
wlgvhu 90
22 Apr 24
Soligenix Announces Pricing of $4.75 Million Public Offering
4:05pm
424B4
pc4 tel66
19 Apr 24
Prospectus supplement with pricing info
4:05pm
8-K
EX-99.1
3i9w amul7ppc
3 Apr 24
Randomized Study with 18 Weeks Continuous Treatment Expected to Replicate and Extend Results from the First, Statistically Significant Phase 3 Study
4:05pm
8-K
EX-99.2
j3ee6rdcvz w9j
3 Apr 24
Randomized Study with 18 Weeks Continuous Treatment Expected to Replicate and Extend Results from the First, Statistically Significant Phase 3 Study
4:05pm
8-K
EX-99.1
r1fan1x0fy0
17 Nov 23
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
4:05pm
8-K
EX-99.1
pdzo12v3
20 Oct 23
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
4:05pm
8-K
EX-99.1
h85mhxbvhfqh0gtn
22 Sep 23
Submission of Matters to a Vote of Security Holders
4:05pm